PLoS ONE · 2011 · 84 citations · 39 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsImmunology Of Infectious DiseasesInnate ImmunityB Cell ActivationB Cell BiologyB-cell ResponsesHumoral Immune ResponsesHumoral ImmunityImmune Responses To InfectionAntibodiesB Cell Responses To InfectionB-cell Mediated ImmunityCell ActivationDengue FeverHumoral Immune EnhancementImmune Cell ActivationPlasmablast Responses
BACKGROUND: Dengue virus is transmitted by mosquitoes and has four serotypes. Cross-protection to other serotypes lasting for a few months is observed following infection with one serotype. There is evidence that low-affinity T and/or B cells from primary infections contribute to the severe syndromes often associated with secondary dengue infections. such pronounced immune-mediated enhancement suggests a dengue-specific pattern of immune cell activation. This study investigates the acute and early convalescent B cell response leading to the generation of cross-reactive and neutralizing antibodies following dengue infection. METHODOLOGY/PRINCIPAL FINDINGS: We assayed blood samples taken from dengue patients with primary or secondary infection during acute disease and convalescence and compared them to samples from patients presenting with non-dengue related fever. Dengue induced massive early plasmablast formation, which correlated with the appearance of polyclonal, cross-reactive IgG for both primary and secondary infection. Surprisingly, the contribution of IgG to the neutralizing titer 4-7 days after fever onset was more than 50% even after primary infection. CONCLUSIONS/SIGNIFICANCE: Poly-reactive and virus serotype cross-reactive IgG are an important component of the innate response in humans during both primary and secondary dengue infection, and "innate specificities" seem to constitute part of the adaptive response in dengue. While of potential importance for protection during secondary infection, cross-reactive B cells will also compete with highly neutralizing B cells and possibly interfere with their development.
39
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Wanwisa Dejnirattisai, Amonrat Jumnainsong, Naruthai Onsirisakul et al. · Science · 2010 · 940 citations
Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies
Adrian F. Ochsenbein, Thomas Fehr, Claudia Lutz et al. · Science · 1999 · 911 citations